 |
|
|
| |
FXR AGONISM BY GS-9674 DECREASES
STEATOSIS AND FIBROSIS IN A MURINE
MODEL OF NASH
|
| |
| |
Reported by Jules Levin
EASL 2016 Nov 11-15 Boston, MA
J.T. Liles1, S. Karnik1, E. Hambruch2, C. Kremoser2, M. Birkel2,
W. J. Watkins1, D. Tumas1, D. Breckenridge1, D. French1
PS066: Friday 15 April 2016
1Gilead Sciences, Foster City, United States;
2Phenex Pharmaceuticals AG, Heidelberg, Germany
|
| |
|
|
|
|
|
